| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |